Back

Optimizing screening intervals for at-risk family members of dilated cardiomyopathy carrying a titin truncating variant: a multi-state model approach

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Prediction and monitoring in heart failure Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Ms Nina Julia Beelen

Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Are patient demographics, comorbidities, and outcomes in acute decompensated heart failure changing? A comparison of new heart failure programme patients from 2013, 2018, and 2023
Doctor L. Maher (Dublin, IE)
Abstract Slides Video
Presentation thumbnail
Full guideline-directed medical therapy in heart failure patients with reduced ejection fraction: a real-world analysis in older patients with outcome implication
Doctor N. Bonini (Modena, IT)
Abstract Slides Video
Presentation thumbnail
Associations of infectious disease and polygenic risk score with heart failure and cardiac remodeling: findings from UK Biobank and ARIC study
Mr J. Zheng (Guangzhou, CN)
Abstract Slides Video
Presentation thumbnail
Socioeconomic and ethnic factors affecting heart failure treatment and prognosis: exploring disparities in clinical outcomes
Doctor J. Fernandes Pedro (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Probability scores for heart failure with preserved ejection fraction predict heart failure hospitalization and mortality in patients with unexplained dyspnea
Doctor S. Moura Ferreira (Hasselt, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Prediction and monitoring in heart failure

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Who should be prioritized for screening for adult onset dilated cardiomyopathy among first degree relatives?
thumbnail
Congress Presentation
Prognostic implications of family screening in Dilated and Arrhythmogenic Cardiomyopathies
thumbnail
Congress Presentation
Genotype-driven prognostication in dilated cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources